[1]CurrentPatentAssignee:JENRINDISCOVERY-WO2014/18695,2014,A1
[1]CurrentPatentAssignee:JENRINDISCOVERY-WO2014/18695,2014,A1Locationinpatent:Paragraph00130;00133
[1]CurrentPatentAssignee:JENRINDISCOVERY-WO2014/18695,2014,A1
Title: JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.
Journal: Bioorganic & medicinal chemistry letters 20121001
Title: Chorvat RJ. Peripherally restricted CB1 receptor blockers. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4751-60.
Title: Knani I, et al. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. Mol Metab. 2016 Oct 22;5(12):1187-1199.
Title: Mukhopadhyay B, et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015 May;61(5):1615-26.